PCA
BSX icon

Pallas Capital Advisors’s Boston Scientific BSX Stock Holding History

Pallas Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Buy
9,535
+925
+11% +$50.2K 0.01% 643
2026
Q1 		$540K Buy
8,610
+5,291
+159% +$423K 0.02% 488
2025
Q4 		$316K Sell
3,319
-3,565
-52% -$350K 0.01% 664
2025
Q3 		$672K Buy
6,884
+721
+12% +$74.7K 0.02% 439
2025
Q2 		$662K Buy
6,163
+2,132
+53% +$216K 0.03% 423
2025
Q1 		$407K Sell
4,031
-42
-1% -$4.23K 0.02% 528
2024
Q4 		$364K Sell
4,073
-343
-8% -$30.2K 0.02% 440
2024
Q3 		$376K Buy
4,416
+10
+0.2% +$788 0.02% 414
2024
Q2 		$333K Sell
4,406
-523
-11% -$38.3K 0.02% 389
2024
Q1 		$338K Buy
4,929
+878
+22% +$56.5K 0.01% 343
2023
Q4 		$234K Buy
+4,051
New +$216K 0.01% 340

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pallas Capital Advisors's BSX Position: Q2 2026 in Review

Pallas Capital Advisors increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $50.2K and bringing the position to 9,535 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #643.

Pallas Capital Advisors first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $672K in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pallas Capital Advisors held 9,535 shares of Boston Scientific worth $407K as of Q2 2026.
  • Pallas Capital Advisors bought 925 Boston Scientific shares in Q2 2026, an estimated $50.2K.
  • Boston Scientific made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #643 holding.
  • Pallas Capital Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Pallas Capital Advisors's Boston Scientific position peaked at $672K in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.